Medical Condition News

RSS

Acupuncture: An effective pain management therapy for pediatric patients

Doctors at Rush University Medical Center are offering pediatric patients diagnosed with chronic illnesses acupuncture therapy to help ease the pain and negative side effects like nausea, fatigue, and vomiting caused by chronic health conditions and intensive treatments.

10 Feb 2010

FDA announces initiative to reduce cancer risk from medical imaging procedures

The U.S. Food and Drug Administration today announced an initiative to reduce unnecessary radiation exposure from three types of medical imaging procedures: computed tomography (CT), nuclear medicine studies, and fluoroscopy.

10 Feb 2010

Johns Hopkins Hospital initiates Phase I trial with Neogenix's NPC-1C

Neogenix Oncology, Inc. (Neogenix) announced today that the Johns Hopkins Hospital has initiated a Phase I trial with the company’s first therapeutic antibody, NPC-1C, in patients with late stage pancreatic or colorectal cancer.

10 Feb 2010

GA²LEN and EAACI warn: Older antihistamines in OTC allergy medications may be hazardous

A joint GA²LEN /EAACI report to be published in "Allergy" and available online on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. The research was funded by GA²LEN, an EU-funded Network of Excellence.

10 Feb 2010

J. Armand Bombardier Foundation donates $200 000 to advance prostate cancer research

Concerned with the health and well being of Canadians, the J. Armand Bombardier Foundation has donated $200 000 to the PROCURE Quebec Prostate Cancer Biobank, a tool to accelerate the pace of research on prostate cancer.

10 Feb 2010

Chamomile extract therapy effective for generalized anxiety disorder

Feeling stressed? Try chamomile! This 'traditional' remedy has been around for years, but how much truth is there behind this old wives' tale?

10 Feb 2010

TI commences Phase IIa clinical trial for its lead molecule in CDH

Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston.

10 Feb 2010

Drinking milk during pregnancy can protect baby against multiple sclerosis

Drinking milk during pregnancy may help reduce your baby's chances of developing multiple sclerosis (MS) as an adult, according to a preliminary study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

10 Feb 2010

Study could lead to new therapeutic strategies for Parkinson's disease

A new study from The Montreal Neurological Institute and Hospital - The Neuro - at McGill University is the first to discover a molecular link between Parkinson's disease and defects in the ability of nerve cells to communicate.

10 Feb 2010

MHI researchers receive $4.8M as grants for genetics and genomic medicine research projects

Two research teams led by Dr. Christine Des Rosiers and Dr. John D. Rioux, both researchers at the Montreal Heart Institute (MHI) and professors at the Universit- de Montr-al, have been awarded grants of $2.5 million and $2.3 million, respectively, to finance research projects on genetics and genomic medicine.

10 Feb 2010

Study challenges clinical myths about effects of depression on cognitive functioning

Many clinicians believe that depression goes hand in hand with cognitive difficulties such as memory problems or difficulties concentrating and paying attention, but a recent review of nearly 20 years of literature conducted by researchers from UT Southwestern Medical Center has found that depression does not always lead to such impairments.

10 Feb 2010

Ligon Discovery, Lycera announce collaboration to identify drug candidates for immune disorders

Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.

10 Feb 2010

ASA Effect test: A tool to identify patients who do not respond to ASA therapy

A convenient test is now available in Canada that determines if the ASA a patient is taking to prevent heart attack and stroke is working. ASA Effect(TM) is offered through LifeLabs Medical Laboratory Services and its network of collection and testing centres.

10 Feb 2010

Early life stress could be a risk factor for cardiovascular disease in adulthood

"We think early life stress increases sensitivity to a hormone known to increase your blood pressure and increases your cardiovascular risk in adult life," said Dr. Jennifer Pollock, biochemist in the Vascular Biology Center at the Medical College of Georgia and corresponding author on the study published online in Hypertension.

10 Feb 2010

Advaxi to receive fund from CRUK for clinical trial of ADXS11-001

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, is pleased to announce that Cancer Research UK (CRUK), the UK philanthropy dedicated to cancer research, has agreed to fund the cost of a clinical trial to investigate the use of ADXS11-001, Advaxis’ lead human papilloma virus (HPV)-directed vaccine candidate, for the treatment of head and neck cancer.

10 Feb 2010

FDA expands indication for Crestor

On Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it.

10 Feb 2010

Insurer to take new role in assessing cancer treatments

UnitedHealthcare, one of the nation's biggest insurance companies, has decided to take a more active role in the care of its policy holders who are being treated for several types of cancer, The Wall Street Journal reports.

9 Feb 2010

AMA supports initiative to combat childhood obesity

"The American Medical Association is pleased to support First Lady Michelle Obama in the Let's Move Campaign. As the nation's largest physician organization, we have long worked to address obesity and are committed to reenergizing our programs and communications this year to focus on children's needs related to obesity prevention and management.

9 Feb 2010

Phase III BSD-2000 Hyperthermia System-chemotherapy combination study for pancreatic cancer initiated

BSD Medical Corporation reports initiation of a randomized, multicenter Phase III clinical study using the BSD-2000 Hyperthermia System in combination with chemotherapy for the treatment of pancreatic cancer patients after R0/R1 surgical resection of their tumor (complete removal or only microscopic tumor remaining).

9 Feb 2010

Survey reveals need for better access to levalbuterol for asthma patients

A recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma, for selected patients.

9 Feb 2010

Medical Condition News

Acupuncture: An effective pain management therapy for pediatric patients

FDA announces initiative to reduce cancer risk from medical imaging procedures

Johns Hopkins Hospital initiates Phase I trial with Neogenix's NPC-1C

GA²LEN and EAACI warn: Older antihistamines in OTC allergy medications may be hazardous

J. Armand Bombardier Foundation donates $200 000 to advance prostate cancer research

Chamomile extract therapy effective for generalized anxiety disorder

TI commences Phase IIa clinical trial for its lead molecule in CDH

Drinking milk during pregnancy can protect baby against multiple sclerosis

Study could lead to new therapeutic strategies for Parkinson's disease

MHI researchers receive $4.8M as grants for genetics and genomic medicine research projects

Study challenges clinical myths about effects of depression on cognitive functioning

Ligon Discovery, Lycera announce collaboration to identify drug candidates for immune disorders

ASA Effect test: A tool to identify patients who do not respond to ASA therapy

Early life stress could be a risk factor for cardiovascular disease in adulthood

Advaxi to receive fund from CRUK for clinical trial of ADXS11-001

FDA expands indication for Crestor

Insurer to take new role in assessing cancer treatments

AMA supports initiative to combat childhood obesity

Phase III BSD-2000 Hyperthermia System-chemotherapy combination study for pancreatic cancer initiated

Survey reveals need for better access to levalbuterol for asthma patients

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News